Pharmacokinetics of ceftazidime and ceftriaxone and their penetration into the ascitic fluid. 1985

G Benoni, and E Arosio, and M G Raimondi, and P Pancera, and A Lechi, and G P Velo

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002442 Ceftazidime Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients. Ceftazidime Anhydrous,Ceftazidime Pentahydrate,Fortaz,Fortum,GR-20263,LY-139381,Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-,Tazidime,GR 20263,GR20263,LY 139381,LY139381
D002443 Ceftriaxone A broad-spectrum cephalosporin antibiotic and cefotaxime derivative with a very long half-life and high penetrability to meninges, eyes and inner ears. Benaxona,Cefatriaxone,Cefaxona,Ceftrex,Ceftriaxon,Ceftriaxon Curamed,Ceftriaxon Hexal,Ceftriaxona Andreu,Ceftriaxona LDP Torlan,Ceftriaxone Irex,Ceftriaxone Sodium,Ceftriaxone Sodium, Anhydrous,Ceftriaxone, Disodium Salt,Ceftriaxone, Disodium Salt, Hemiheptahydrate,Lendacin,Longacef,Longaceph,Ro 13-9904,Ro-13-9904,Ro13-9904,Rocefalin,Rocefin,Rocephin,Rocephine,Tacex,Terbac,Anhydrous Ceftriaxone Sodium,Ro 13 9904,Ro 139904,Ro13 9904,Ro139904
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001202 Ascitic Fluid The serous fluid of ASCITES, the accumulation of fluids in the PERITONEAL CAVITY. Peritoneal Effusion,Peritoneal Fluid,Ascitic Fluids,Effusion, Peritoneal,Fluid, Ascitic,Fluid, Peritoneal,Peritoneal Effusions,Peritoneal Fluids

Related Publications

G Benoni, and E Arosio, and M G Raimondi, and P Pancera, and A Lechi, and G P Velo
September 1981, The Journal of antimicrobial chemotherapy,
G Benoni, and E Arosio, and M G Raimondi, and P Pancera, and A Lechi, and G P Velo
January 1991, Fundamental & clinical pharmacology,
G Benoni, and E Arosio, and M G Raimondi, and P Pancera, and A Lechi, and G P Velo
January 1987, European journal of clinical pharmacology,
G Benoni, and E Arosio, and M G Raimondi, and P Pancera, and A Lechi, and G P Velo
January 1989, European journal of clinical pharmacology,
G Benoni, and E Arosio, and M G Raimondi, and P Pancera, and A Lechi, and G P Velo
March 1993, Biopharmaceutics & drug disposition,
G Benoni, and E Arosio, and M G Raimondi, and P Pancera, and A Lechi, and G P Velo
September 1981, The Journal of antimicrobial chemotherapy,
G Benoni, and E Arosio, and M G Raimondi, and P Pancera, and A Lechi, and G P Velo
August 1996, The Japanese journal of antibiotics,
G Benoni, and E Arosio, and M G Raimondi, and P Pancera, and A Lechi, and G P Velo
October 1988, World journal of surgery,
G Benoni, and E Arosio, and M G Raimondi, and P Pancera, and A Lechi, and G P Velo
January 1985, Developmental pharmacology and therapeutics,
G Benoni, and E Arosio, and M G Raimondi, and P Pancera, and A Lechi, and G P Velo
March 1998, The Pediatric infectious disease journal,
Copied contents to your clipboard!